Pages that link to "Q48257128"

The following pages link to Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure (Q48257128):

Displaying 37 items.

• Relationship of left atrial global peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in patients presenting with non-ST elevation myocardial infarction (Q34428306) (← links)
• The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting (Q34796770) (← links)
• Brain and other natriuretic peptides: molecular aspects (Q35677302) (← links)
• Can natriuretic peptides be used for the diagnosis of diastolic heart failure? (Q35677306) (← links)
• Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction (Q36816167) (← links)
• Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction (Q36834363) (← links)
• Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment (Q36835952) (← links)
• Relation of left atrial peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in patients presenting with ST-elevation myocardial infarction (Q37004126) (← links)
• Updating the role of natriuretic peptide levels in cardiovascular disease (Q37959158) (← links)
• Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure (Q37980254) (← links)
• Left atrial strain: a new parameter for assessment of left ventricular filling pressure. (Q38674602) (← links)
• Effects of intermittent and long-term glucose-insulin-potassium infusion in patients with systolic heart failure. (Q41674725) (← links)
• Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists. (Q43867418) (← links)
• Relationship of left atrial global peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in end-stage renal disease patients with preserved left ventricular ejection fraction (Q46601541) (← links)
• Cardiac cephalgia: an underdiagnosed condition? (Q46863170) (← links)
• Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure (Q47641198) (← links)
• B-type natriuretic peptide levels in congenital heart disease (Q48089433) (← links)
• Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale (Q48125940) (← links)
• Mechanical ventilation strategies alter cardiovascular biomarkers in an infant rat model. (Q48143031) (← links)
• Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure (Q48225190) (← links)
• Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise (Q48227095) (← links)
• Brain natriuretic peptide and fluid volume homeostasis--studies during cardiopulmonary bypass surgery (Q48240180) (← links)
• Amino-terminal pro-brain natriuretic peptide in normal and hypertensive pregnancy (Q48590303) (← links)
• Correlation between plasma brain natriuretic peptide concentration and lung thallium-201 uptake on exercise thallium perfusion images (Q48611151) (← links)
• Practical implications of current natriuretic peptide research (Q48624965) (← links)
• Relation of left ventricular end-diastolic pressure and N-terminal pro-brain natriuretic peptide level with left atrial deformation parameters (Q48784334) (← links)
• Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF. (Q49385586) (← links)
• Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy (Q50515497) (← links)
• Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure. (Q51799502) (← links)
• Leg edema, ST-T abnormalities, and high BNP values are important signs of heart failure in the elderly. (Q51965099) (← links)
• Significance of Raised Natriuretic Peptides After Bicaval and Standard Cardiac Transplantation (Q58864709) (← links)
• Brain natriuretic peptide as a marker of cardiac involvement in hypertension (Q61460190) (← links)
• Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure-A Comparative Review (Q61807150) (← links)
• Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]) (Q71720357) (← links)
• Measurement of plasma brain natriuretic peptide in heart failure (Q72672685) (← links)
• Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction (Q74347919) (← links)
• Alleviation of salt-induced exacerbation of cardiac, renal, and visceral fat pathology in rats with metabolic syndrome by surgical removal of subcutaneous fat (Q98302827) (← links)